These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 22108039

  • 21. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA, Barley J.
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. HPV vaccine acceptability in Ghana, West Africa.
    Coleman MA, Levison J, Sangi-Haghpeykar H.
    Vaccine; 2011 May 23; 29(23):3945-50. PubMed ID: 21481327
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
    Black SB, Cimino CO, Hansen J, Lewis E, Ray P, Corsaro B, Graepel J, Laufer D.
    Pediatr Infect Dis J; 2006 Apr 23; 25(4):306-11. PubMed ID: 16567981
    [Abstract] [Full Text] [Related]

  • 30. Chapter 24: Psychosocial aspects of vaccine acceptability.
    Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B.
    Vaccine; 2006 Aug 31; 24 Suppl 3():S3/201-9. PubMed ID: 16950008
    [Abstract] [Full Text] [Related]

  • 31. Eligibility and willingness of first-year students entering university to participate in a HPV vaccination catch-up program.
    Mehu-Parant F, Rouzier R, Soulat JM, Parant O.
    Eur J Obstet Gynecol Reprod Biol; 2010 Feb 31; 148(2):186-90. PubMed ID: 19926199
    [Abstract] [Full Text] [Related]

  • 32. Improving adolescent health: focus on HPV vaccine acceptance.
    Zimet GD.
    J Adolesc Health; 2005 Dec 31; 37(6 Suppl):S17-23. PubMed ID: 16310137
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM, Baker L, Starr SE, Levine BL, Books E, Plotkin SA.
    Pediatrics; 1986 Oct 31; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [Abstract] [Full Text] [Related]

  • 38. [Chickenpox: sufficient reasons for the introduction of vaccination].
    Rümke H, de Groot R.
    Ned Tijdschr Geneeskd; 2006 Dec 02; 150(48):2630-2. PubMed ID: 17205937
    [Abstract] [Full Text] [Related]

  • 39. Attitudes about human papillomavirus vaccine among family physicians.
    Riedesel JM, Rosenthal SL, Zimet GD, Bernstein DI, Huang B, Lan D, Kahn JA.
    J Pediatr Adolesc Gynecol; 2005 Dec 02; 18(6):391-8. PubMed ID: 16338604
    [Abstract] [Full Text] [Related]

  • 40. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul 02; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.